Search clinical trials for: Intravitreal injection ranibizumab

Total 10419 results

Peter A Campochiaro, MD
Genentech, Inc.

Completed

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions (LVO)

Macular Edema | Retinal Vein Occlusion

United States
Qena Faculty of medicine, South Valley University

Recruiting

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema

Egypt
Instituto de Olhos de Goiania

Unknown

Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration (AxL-2009)

Age Related Macular Degeneration

Brazil
Barnes Retina Institute
Massachusetts Eye and Ear Infirmary; Long Island Vitreoretinal Consultants; Illinois... and other collaborators

Completed

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion (CRAVE)

Macular Edema | Retinal Vein Occlusion

United States
Vista Klinik

Completed

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Fundació Institut Germans Trias i Pujol

Completed

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Diabetic Macular Edema | Vitreomacular Interface | Anti-VEGF Treatment
Hawaii Pacific Health
Genentech, Inc.

Completed

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL)

Polypoidal Choroidal Vasculopathy

United States
Pusan National University Hospital
Novartis

Completed

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Exudative Age-related Macular Degeneration

Korea, Republic of
University Hospital, Bonn
Novartis

Completed

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Choroidal Neovascularization

Germany
University Hospital, Bonn
Novartis

Completed

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Type 2 Idiopathic Macular Telangiectasia

Germany
Hospital Regional de São José - Dr. Homero de Miranda...

Unknown

Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage

Diabetic Retinopathy | Vitreous Hemorrhage

Brazil
Ameera Gamal Abdelhameed

Completed

Intravitreal Ranibizumab in Recurrent ROP

Retinopathy of Prematurity

Egypt
Retina Research Foundation

Completed

Scotoma Reduction in AMD Patients Treated With Ranibizumab (SALVAGE)

Macular Degeneration

United States
Attila Vajas
Semmelweis University

Unknown

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

Diabetic Retinopathy

Hungary
Asociación para Evitar la Ceguera en México
Centro Medico Issemym

Withdrawn

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Subfoveal Choroidal Neovascularization

Mexico
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.

Retinal Vein Occlusion | Age Related Macular Degeneration

Chile
Medical University of Vienna

Completed

Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Austria
Jeffrey S Heier
Kato Pharmaceuticals, Inc.

Completed

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

Vitreomacular Traction | Vitreomacular Adhesion | Vitreomacular Attachment

United States
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Fundação de Apoio ao...

Unknown

Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study) (INIPE)

Proliferative Diabetic Retinopathy
University Hospital Muenster
Novartis

Completed

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Pigment Epithelial Detachment

Germany
Yonsei University

Completed

Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Neovascular Age-related Macular Degeneration

Korea, Republic of
Kantonsspital Aarau
University Hospital Inselspital, Berne

Completed

Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease

Retinopathy of Prematurity

Switzerland
Indonesia University
Bayer

Completed

Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection

Diabetic Retinopathy | Diabetic Macular Edema | Clinically Significant Macular Edema

Indonesia
Novartis Pharmaceuticals

Completed

Canadian Treat and Extend Analysis Trial With Ranibizumab (CAN-TREAT)

wetAMD

Canada
Opthea Limited

Completed

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Neovascular Age-related Macular Degeneration

United States, Czechia, France, Hungary, Israel, Italy, Latvia, Poland, Spain, United Kingdom
Afyonkarahisar Health Sciences University

Completed

Effect of Music Intervention on Intravitreal Injection

Music Intervention

Turkey
Second Affiliated Hospital of Xi'an Jiaotong University

Completed

The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma

Neovascular Glaucoma

China
Hoffmann-La Roche

Active, not recruiting

This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab (Pagoda)

Diabetic Macular Edema

United States
University Hospital, Basel, Switzerland

Completed

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Age-Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Egyptian Biomedical Research Network

Completed

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

Diabetic Retinopathy | Visual Acuity | Ranibizumab | Subfoveal Choroidal Thickness | Intravitreal

Egypt
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) (VIDI)

Diabetes Mellitus | Diabetic Macular Edema

United States
Hoffmann-La Roche

Active, not recruiting

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Diabetic Retinopathy

United States, Puerto Rico
New England Retina Associates

Withdrawn

Ranibizumab as a Rescue Therapy for Diabetic Macular Edema

Diabetic Macular Edema

United States
Beijing Hospital

Completed

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

Diabetic Macular Edema

China
Hemera Biosciences

Withdrawn

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Geographic Atrophy | Dry Age-related Macular Degeneration | Gene Therapy | Intravitreal Injection
Ain Shams University

Completed

New Concepts in Diabetic Macular Edema (DME) (DME)

Diabetes Mellitus, With Complications
University of Pecs
University of Debrecen

Unknown

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion (BRAVO)

Macular Edema | Retinal Vein Occlusion

Hungary
Dongyang People's Hospital

Recruiting

Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab (JQMMT+RA)

Macular Cystoid Edema

China
Dar El Oyoun Hospital
Cairo University

Completed

Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm. (RAM)

Retinal Artery Macroaneurysm

Egypt
Peregrine Eye and Laser Institute

Completed

Time Efficiency Comparison of Two IntraVitreal Injection Techniques (TIVI)

Diabetic Macular Edema | Choroidal Neovascularization | Neovascular Age-related Macular Degeneration | Uveitic Macular Edema | Retinal Vein Occlusion With Macular Edema

Philippines
Universidad Autonoma de San Luis Potosí
Hospital Central "Dr. Ignacio Morones Prieto"

Completed

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Eye Diseases | Premature Birth | Retinal Disease | Retinopathy of Prematurity Both Eyes

Mexico
Eye & ENT Hospital of Fudan University

Unknown

Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Cataract Diabetic
Hoffmann-La Roche

Completed

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)

Neovascular Age-Related Macular Degeneration

United States
Ophthotech Corporation

Terminated

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Age-Related Macular Degeneration

Italy, Canada, Switzerland, United States, United Kingdom, Austria, Belgium, Brazil, Czechia, Estonia, Latvia, Poland, Slovakia
São Paulo State University

Completed

ETDRS PRP With IVR Versus Retinal Photocoagulation Targeted to Ischemic Retina With IVR for the Treatment of PDR

Diabetic Retinopathy
Benha University

Recruiting

BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema

Macular Edema

United Arab Emirates
Ophthotech Corporation

Terminated

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Age-Related Macular Degeneration

Israel, United States, Germany, Denmark, France, Turkey, Hungary, Colombia, Australia, Argentina, Spain
Xun Xu
Peking University; Zhongshan Ophthalmic Center, Sun Yat-sen University; Air Force... and other collaborators

Unknown

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Age-Related Macular Degeneration | Polypoidal Choroidal Vasculopathy | Pathological Myopia | Conbercept | Pharmacogenomic

China
Chengdu Kanghong Biotech Co., Ltd.
Beijing DMS Pharma Ltd.; The Digital Angiography Reading Center (DARC)

Completed

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD (AURORA)

Neovascular Age-related Macular Degeneration

China
Southern New England Retina Associates
Genentech, Inc.

Completed

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

Retinal Ischemia

United States

Search clinical trials for: Intravitreal injection ranibizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations